About 50 results
Open links in new tab
  1. Biotech and Pharma Industry News | BioPharma Dive

    BioPharma Dive provides news and analysis for biotech and biopharmaceutical executives. We cover topics like clinical trials, drug discovery and development, pharma marketing, FDA approvals and …

  2. Pharma News | BioPharma Dive

    4 days ago · The latest pharma news for biotech and biopharmaceutical professionals

  3. Biotech News | BioPharma Dive

    5 days ago · The latest biotech news for biopharmaceutical professionals

  4. Deep Dive - BioPharma Dive

    6 days ago · BioPharma Biotech startups are built on venture capital. Track funding rounds here. Biotechs backed by the venture firms BioPharma Dive tracks have raised nearly $700 million this …

  5. Clinical Trial News | BioPharma Dive

    5 days ago · The latest clinical trial news for biotech and biopharmaceutical professionals

  6. 10 clinical trials to watch the rest of 2025 | BioPharma Dive

    Jan 2, 2025 · 10 clinical trials to watch the rest of 2025 Expected readouts in obesity, lung cancer and atopic dermatitis headline a series of study results that could give the biotechnology sector a boost in …

  7. Gene Therapy News | BioPharma Dive

    4 days ago · The latest gene therapy news for biotech and biopharmaceutical professionals

  8. The biopharma industry outlook on 2025: Uncertainty and change

    Jan 24, 2025 · The biopharma industry outlook on 2025: Uncertainty and change The Trump administration is bringing new instability to a sector already grappling with a shaky market as well as …

  9. 5 questions facing emerging biotech in 2025 | BioPharma Dive

    Jan 14, 2025 · 5 questions facing emerging biotech in 2025 Competition from China and a barely open “IPO window” are among the challenges confronting young drugmakers this year.

  10. The top biopharma conferences in 2026 | BioPharma Dive

    Oct 1, 2025 · The top biopharma conferences in 2026 Medical meetings often feature important clinical trial results, making them barometers of biotech and pharma companies’ research progress. Here’s a …